blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1746984

EP1746984 - USE OF TARGETED OXIDATIVE THERAPEUTIC FORMULATION IN TREATMENT OF DIABETES AND OBESITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.04.2010
Database last updated on 02.09.2024
Most recent event   Tooltip30.04.2010Application deemed to be withdrawnpublished on 02.06.2010  [2010/22]
Applicant(s)For all designated states
Torquin, LLC
5900 SW Parkway, Suite 520
Austin, Texas 78735 / US
[2009/27]
Former [2007/05]For all designated states
Hofmann, Robert F.
3105 Toro Ring
Austin, TX 78746-2432 / US
Inventor(s)01 / see applicant
...
 [2007/05]
Representative(s)Fisher, Adrian John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2007/05]Fisher, Adrian John, et al
CARPMAELS & RANSFORD 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date05746254.105.05.2005
[2007/05]
WO2005US15846
Priority number, dateUS20040568542P06.05.2004         Original published format: US 568542 P
[2007/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005107728
Date:17.11.2005
Language:EN
[2005/46]
Type: A2 Application without search report 
No.:EP1746984
Date:31.01.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2005 takes the place of the publication of the European patent application.
[2007/05]
Search report(s)International search report - published on:EP08.02.2007
ClassificationIPC:A61K47/46, A61P3/10, A61P3/04
[2007/15]
CPC:
A61K31/045 (EP,US); A61K31/365 (EP,KR,US); A61K31/525 (EP,US);
A61K31/538 (EP,KR,US); A61K31/555 (EP,US); A61K47/46 (EP,US);
A61K9/0019 (EP,US); A61P3/04 (EP); A61P3/10 (EP) (-)
Former IPC [2007/05]A61K31/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/05]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERWENDUNG EINER GEZIELTEN OXIDATIVEN THERAPEUTISCHEN FORMULIERUNG BEI DER BEHANDLUNG VON DIABETES UND FETTSUCHT[2007/05]
English:USE OF TARGETED OXIDATIVE THERAPEUTIC FORMULATION IN TREATMENT OF DIABETES AND OBESITY[2007/05]
French:UTILISATION D'UNE PREPARATION THERAPEUTIQUE OXYDATIVE CIBLEE DANS LE TRAITEMENT DU DIABETE ET DE L'OBESITE[2007/05]
Entry into regional phase01.12.2006National basic fee paid 
01.12.2006Designation fee(s) paid 
01.12.2006Examination fee paid 
Examination procedure01.12.2006Amendment by applicant (claims and/or description)
01.12.2006Examination requested  [2007/05]
29.06.2009Communication of intention to grant the patent
10.11.2009Application deemed to be withdrawn, date of legal effect  [2010/22]
28.12.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/22]
Fees paidRenewal fee
01.12.2006Renewal fee patent year 03
31.10.2008Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.05.200804   M06   Fee paid on   31.10.2008
31.05.200905   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]US5190979  (HERMAN STEPHEN [US]) [AD] 1-26 * column 1, line 13 - line 19 * * column 6, line 12 - column 7, line 36 *;
 [A]US2002177585  (HOFMANN ROBERT F [US], et al) [A] 1-26 * page 2, paragraph 21 * * claims 1-55 *;
 [A]US2003032677  (HOFMANN ROBERT F [US]) [A] 1-26 * page 2, paragraph 19 * * claims 1-71 *;
 [E]WO2005110484  (HOFMANN ROBERT F [US]) [E] 1-26 * page 1, paragraph 2 ** page 9, line 4 - line 7 *;
 [E]WO2006002302  (HOFMANN ROBERT F [US]) [E] 1-26 * page 7, paragraph 25 * * page 9, line 3 - line 6 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.